Asma grave eosinofilico, studio conferma efficacia benralizumab

Asma grave eosinofilico, studio conferma efficacia benralizumab

(Adnkronos) – I risultati presentati al Congresso Ers 2025

Read More

Tag: Nessun tag

Add a Comment

Your email address will not be published. Required fields are marked *